1. Home
  2. JYD vs PRPO Comparison

JYD vs PRPO Comparison

Compare JYD & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYD
  • PRPO
  • Stock Information
  • Founded
  • JYD 2001
  • PRPO N/A
  • Country
  • JYD China
  • PRPO United States
  • Employees
  • JYD N/A
  • PRPO N/A
  • Industry
  • JYD Oil Refining/Marketing
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • JYD Consumer Discretionary
  • PRPO Industrials
  • Exchange
  • JYD Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • JYD 17.8M
  • PRPO 17.1M
  • IPO Year
  • JYD 2023
  • PRPO N/A
  • Fundamental
  • Price
  • JYD $0.19
  • PRPO $14.26
  • Analyst Decision
  • JYD
  • PRPO
  • Analyst Count
  • JYD 0
  • PRPO 0
  • Target Price
  • JYD N/A
  • PRPO N/A
  • AVG Volume (30 Days)
  • JYD 1.6M
  • PRPO 17.8K
  • Earning Date
  • JYD 08-12-2025
  • PRPO 08-12-2025
  • Dividend Yield
  • JYD N/A
  • PRPO N/A
  • EPS Growth
  • JYD N/A
  • PRPO N/A
  • EPS
  • JYD N/A
  • PRPO N/A
  • Revenue
  • JYD $77,444,271.00
  • PRPO $20,029,000.00
  • Revenue This Year
  • JYD N/A
  • PRPO N/A
  • Revenue Next Year
  • JYD N/A
  • PRPO N/A
  • P/E Ratio
  • JYD N/A
  • PRPO N/A
  • Revenue Growth
  • JYD 13.54
  • PRPO 26.67
  • 52 Week Low
  • JYD $0.09
  • PRPO $3.90
  • 52 Week High
  • JYD $8.00
  • PRPO $16.89
  • Technical
  • Relative Strength Index (RSI)
  • JYD 39.83
  • PRPO 56.56
  • Support Level
  • JYD $0.22
  • PRPO $14.10
  • Resistance Level
  • JYD $0.25
  • PRPO $14.96
  • Average True Range (ATR)
  • JYD 0.02
  • PRPO 0.88
  • MACD
  • JYD 0.01
  • PRPO -0.19
  • Stochastic Oscillator
  • JYD 19.61
  • PRPO 39.77

About JYD Jayud Global Logistics Limited

Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: